Dana-Farber Cancer Institute ( Site 1130)

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Squamous Cell, Skin Neoplasms

Studies at this site

• A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007) — Stopped early